PHASE II NON RANDOMIZED OPEN CLINICAL MANAGEMENT OF SIDDHA MEDICINE PASUNEER KADUKKAI CHOORANAM FOR MULAI MOOLAM (HAEMORRHOIDS)

PHASE II NON RANDOMIZED OPEN CLINICAL EVALUATION OF SIDDHA MEDICINE PASUNEER KADUKKAI CHOORANAM FOR MULAI MOOLAM (HAEMORRHOIDS)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047257

Enrollment

Registered

2022-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K640- First degree hemorrhoids

Interventions

Intervention1: PASUNEER KADUKKAI CHOORANAM: This is a siddha herbal drug for the management of Haemorrhoids Intervention2: PASUNEER KADUKKAI CHOORANAM: 4 gm BD oral dose with luke warm water after foo

Eligibility

Inclusion criteria

Inclusion criteria: Both sex, age 18 to 60 years. Patients with appropriate symptoms like, bleeding during defecation, constipation. Pain in the Anal region. First degree Haemorrhoids. Patients who are all willing to give blood sample at subsequent visit are involved in this study.

Exclusion criteria

Exclusion criteria: Second degree Haemorrhoids External Haemorrhoids Fissure in ano Fistula Diabetes Mellitus CA Rectum Rectal prolaps

Design outcomes

Primary

Measure	Time frame
Outcome is mainly from one week of medication and is assesed by PNR bleed scale reduction in bleeding inflammation pain and irritationTimepoint: 1 week	—

Secondary

Measure	Time frame
Secondary outcome is mainly assessed by comparing the safety parameters before and after treatmentTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr J JAYABARATHI

Government Siddha Medical College

rangasamymenaka75@gmail.com9444669661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026